CAMP4 Therapeutics Corporation (CAMP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CAMP4 Therapeutics Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.32x | -1.97x | -8.76x | -2.64x | -12.13x | -17.29x |
| P/B Ratio | 3.90x | 1.61x | -4.99x | -1.05x | 4.71x | 3.68x |
| P/S Ratio | 53.24x | 156.16x | 0.00x | 371.36x | 1.28x | 1.19x |
| Profitability | ||||||
| Gross Margin | 53.1% | 100.0% | 0.0% | 100.0% | 41.2% | 39.7% |
| Operating Margin | -1488.3% | -8142.3% | 0.0% | -14822.6% | -5.2% | -1.3% |
| Net Margin | -2298.5% | -7943.4% | 0.0% | -14083.1% | -10.5% | -6.9% |
| EBITDA Margin | -1441.5% | -7882.2% | 0.0% | -14343.1% | 2.5% | 5.9% |
| Liquidity | ||||||
| Current Ratio | 7.35x | 6.92x | 10.62x | 5.13x | 2.04x | 2.00x |
| Quick Ratio | 7.35x | 6.92x | 10.62x | 5.13x | 1.83x | 1.70x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.14x | -0.16x | -0.09x | 2.61x | 2.12x |
YoY = year-over-year change. Source: FMP..